ERBB2 and breast cancer: In the case of human epidermal growth factor receptor 2 positive (HER2+) breast cancer, Gasdermin B (GSDMB) overexpression was found to be associated with increased resistance to therapy and aggressive tumor behavior, indicating its role in protective autophagy [232].